Safety of limited therapeutic monitoring after high-dose methotrexate in developing countries

Pediatr Blood Cancer. 2020 Nov;67(11):e28540. doi: 10.1002/pbc.28540. Epub 2020 Jun 23.

Authors

Lisa Gennarini¹, Peter D Cole²

Affiliations

¹ Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, New York.
² Division of Pediatric Hematology and Oncology, Robert Wood Johnson Medical School, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.

PMID: 32573929
DOI: 10.1002/pbc.28540

No abstract available

Publication types

Comment

MeSH terms

Developing Countries
Drug Monitoring
Humans
India
Methotrexate* / adverse effects
Pharmaceutical Preparations*

Substances

Pharmaceutical Preparations
Methotrexate